Lymphoma T-cell Cutaneous
📧 Sign up to get email alerts when something new happens for Lymphoma T-cell Cutaneous.
Sign up freeTop drugs studied for this disease
-
EMA withdrawal · 2009-02-17EMA Application withdrawn: Vorinostat MSD (vorinostat) — Merck Sharp Dohme Limited
EMA withdrew the application for vorinostat (MSD) by Merck Sharp & Dohme Limited.